Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Stock market IPO share price Nasdaq
Biotech

Lycia aims for $228M IPO to advance food allergy rival to Xolair

Lycia is banking on a $227.8 million IPO as the biotech seeks to finance its protein degraders for autoimmune, inflammatory and allergic diseases.
James Waldron Oct 20, 2026 10:52am
milestones

Rapport's ph. 2 bipolar mania win impresses analysts

Oct 20, 2026 9:19am
From Scientific Hypothesis to Clinical Practice The Next Chapter for CLDN182

The next chapter of CLDN18.2-directed innovation

Brought to you by Astellas Pharma US
Hengrui

How Hengrui became a go-to source of China biopharma innovation

Oct 20, 2026 8:00am
Aligning drug discovery around patient benefit from the outset Connecting human insights to better decisions

Aligning drug discovery around patient benefit from the outset: Connecting human insights to better decisions

Brought to you by IQVIA Laboratories
mechanical ventilator for patient in hospital

Nano24’s exosome therapy reduces respiratory failure in ph. 2

Oct 20, 2026 7:00am